OCTOBER 2009
|
Citations predict four Nobel Prize winners This year we successfully predicted four Nobel Prize winners in two categories—Economics and Physiology or Medicine. FULL STORY> |
|
Innovation hot spots: mining patent data for tomorrow's breakthroughs Our IP Market Report on innovation hot spots shows that areas of sharpest growth include biofuels based on algae, cell phone data/wireless network roaming and lab-on-a-chip nanotechnology. FULL STORY> |
|
Treating H1N1 the innovation behind the science The recent outbreak of the swine influenza virus (H1N1) has precipitated an immediate response from the international health community, governments and pharmaceutical industry alike. As stock prices of certain pharmaceutical companies such as Biota soar, we may ask who the originators, current manufacturers and patent holders of these life-saving drugs currently in use are FULL STORY> |
|
India's scientific output to overtake the G8 by 2020? A new Thomson Reuters study predicts India's research productivity will be on par with most G8 nations within seven to eight years and could overtake them between 2015 and 2020. FULL STORY> |
|
Outlook and issues for the biotechnology sector Thomson Reuters and the Biotechnology Industry Organization present a comprehensive assessment of Wall Street's perception of, and outlook for, the biotechnology sector. FULL STORY> |
|
Alternative energy powers up Who will win the international race to secure energy independence and to establish dominance in alternative energy technology? FULL STORY> |
|
Intellectual property and its role in business success Most small businesses concentrate their attention on cash flow and profits to survive; but intangible assets may be vital for the long-term survival of the business. FULL STORY> |
|
Citation-based research evaluation Learn more about InCites and the methodology behind citation-based research evaluation FULL STORY> |
|
Addressing patent creation backlogs The cause of a backlog in a patent creation entity can vary greatly. In his latest white paper—Addressing challenges with backlog in a patent creation entity —Donal O’Connell presents possible solutions for these challenges. FULL STORY> |
|
The Japanese generic drug market Until recently, Japan seemed all but closed to incursion by foreign generic manufacturers. In an important new white paper, Thomson Reuters reveals the true picture of the generic market in Japan and the tactics that can ensure success in this market. FULL STORY> |
|
ResearcherID - increasing the visibility of researchers and their work By September 2009 there were 46,000 members of the Thomson Reuters ResearcherID community. FULL STORY> |
|
Brazilian science on the rise Brazil has been moving consistently upward in the output and impact of its scientific publications—but can it stay ahead of India and China, fellow members of the so-called BRIC nations that are predicted by some to have the resources and economic potential to give them a significant share of the world’s future economic growth? FULL STORY> |
|
Tools to promote your ISI Web of Knowledge subscription Do your users know what resources your library offers, and how to use them effectively? FULL STORY> |
|
The organ growers Tissue engineering is being applied to develop patient-specific replacement tissue, with the ultimate goal of fabricating a brand new organ. FULL STORY> |
|
Thomson Innovation training 24 7 Wherever you are in the world, Thomson Innovation training is available at the click of a mouse. FULL STORY> |
|
Disease detectives Learn how Caris Diagnostics are using molecular profiling in the quest for personalized medicine. FULL STORY> |
|
Cure for Needy - bringing down the production costs of orphan drugs The Cure for Needy project believes that a global pool of information can help chemists and pharmaceutical manufacturers to bring down the production costs of orphaned drugs. Thomson Reuters has added its support to the project by providing access to some selected routes of synthesis in Prous Science Integrity®. FULL STORY> |
|
Call for nominations: IUPAC–Richter Prize in Medicinal Chemistry The IUPAC–Richter Prize in Medicinal Chemistry is to be awarded to an internationally recognized scientist whose activities have made an outstanding contribution to the practice of medicinal chemistry or to an outstanding example of new drug discovery. FULL STORY> |